Sutro Biopharma STRO Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's change in other assets?
- Sutro Biopharma (STRO) reported change in other assets of $1M in Q1 2026.
- How has Sutro Biopharma's change in other assets changed year-over-year?
- Sutro Biopharma's change in other assets increased by 9218.2% year-over-year, from -$11K to $1M.
- What is the long-term trend for Sutro Biopharma's change in other assets?
- Over 2 years (2022 to 2025), Sutro Biopharma's change in other assets has grown at a 133.7% compound annual growth rate (CAGR), from $3.54M to -$19.35M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.